Koers Univo Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Aandelen
UNVO
IL0010935588
Biotechnologie & Medisch Onderzoek
Omzet 2019 | 0,82 3,01 0,76 | Omzet 2020 | 33,68 122,84 31 | Marktkapitalisatie | 75,11 mln. 274 mln. 69,13 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -11 mln. -40,12 mln. -10,12 mln. | Nettowinst (verlies) 2020 | - 0 0 | EV/omzet 2019 | 35.568.323 x |
Nettoliquiditeiten 2019 | 22,82 mln. 83,23 mln. 21 mln. | Nettoschuld 2020 | 4,12 mln. 15,03 mln. 3,79 mln. | EV/omzet 2020 | 2.352.431 x |
K/w-verhouding 2019 |
-5,92
x | K/w-verhouding 2020 |
426
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 59,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 47 | 04-04-93 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 63 | 15-07-19 |
Golan Bitton
CEO | Chief Executive Officer | 47 | 04-04-93 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,72% | 46,21 mld. | |
+35,14% | 40,04 mld. | |
+4,84% | 39,92 mld. | |
-9,43% | 28,33 mld. | |
+17,47% | 27,43 mld. | |
-22,99% | 18,57 mld. | |
+10,88% | 13,46 mld. | |
+27,53% | 12,02 mld. | |
-6,84% | 11,3 mld. |